DPT: A Potential Drug Target and Biomarker (G1805)

Target Name: DPT

NCBI ID: G1805

Content of Review Report on DPT Target / Biomarker

DPT

DPT: A Potential Drug Target and Biomarker

Drug-resistant bacteria are a major public health concern, and the development of new treatments is crucial to combatting these bacteria. One potential drug target for these bacteria is DPT, a protein that is expressed in high levels in the bloodstream of patients with complicated infections. In this article, we will discuss DPT as a drug target and biomarker, and its potential for treating drug-resistant bacteria.

DPT: Definition and Function

DPT is a 24-kDa protein that is expressed in high levels in the bloodstream of patients with complicated infections, including urinary tract infections, pneumonia, and sepsis. It is a member of the Integrin 伪6尾6 family, which is involved in cell-cell adhesion and migration. DPT functions as a critical regulator of bacterial adhesion and migration, allowing bacteria to spread throughout the body and cause infections.

DPT Interacts with Antibiotics

DPT has been shown to interact with a wide range of antibiotics, including vancomycin, ciprofloxacin, and quimolvincin. These interactions may limit the effectiveness of these antibiotics, particularly in the treatment of drug-resistant bacteria. For example, studies have shown that DPT can inhibit the activity of vancomycin and quimolvincin, and may reduce their efficacy in the treatment of complicated infections.

DPT as a Drug Target

DPT is a potential drug target for the treatment of drug-resistant bacteria. By inhibiting its function, DPT may prevent bacteria from adhering to the endothelium and causing infections. This could be an effective way to treat antibiotic-resistant organisms, such as those that are causing complicated infections.

DPT as a Biomarker

DPT may also be used as a biomarker for monitoring the effectiveness of antibiotics in the treatment of drug-resistant bacteria. By measuring the levels of DPT in the bloodstream, doctors can determine the effectiveness of different antibiotics and monitor for the development of antibiotic resistance.

Conclusion

In conclusion, DPT is a protein that has been shown to interact with a wide range of antibiotics, and may be a potential drug target for the treatment of drug-resistant bacteria. Further research is needed to fully understand its function and potential as a biomarker for monitoring the effectiveness of antibiotics. If its potential as a drug target is validated, DPT may be a valuable tool in the fight against antibiotic-resistant bacteria, and could lead to new treatments for serious infections.

Protein Name: Dermatopontin

Functions: Seems to mediate adhesion by cell surface integrin binding. May serve as a communication link between the dermal fibroblast cell surface and its extracellular matrix environment. Enhances TGFB1 activity. Inhibits cell proliferation. Accelerates collagen fibril formation, and stabilizes collagen fibrils against low-temperature dissociation (By similarity)

The "DPT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DPT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets